Thermo Fisher closes $3.1B Olink acquisition after UK antitrust review is cleared
Life sciences giant Thermo Fisher on Wednesday closed its $3.1 billion deal for Olink, adding protein analysis to its drug discovery tools in a move …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.